Characterization of a Novel, Water-Soluble Hydrogen Sulfide–Releasing Molecule (GYY4137)
Top Cited Papers
- 6 May 2008
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 117 (18), 2351-2360
- https://doi.org/10.1161/circulationaha.107.753467
Abstract
Background— The potential biological significance of hydrogen sulfide (H 2 S) has attracted growing interest in recent years. The aim of this study was to characterize a novel, water-soluble, slow-releasing H 2 S compound [morpholin-4-ium 4 methoxyphenyl(morpholino) phosphinodithioate (GYY4137)] and evaluate its use as a tool to investigate the cardiovascular biology of this gas. Methods and Results— The acute vasorelaxant effect of drugs was assessed in rat aortic rings and perfused rat kidney in vitro and in the anesthetized rat in vivo. The chronic effect of GYY4137 on blood pressure in normotensive and spontaneously hypertensive rats was determined by tail-cuff plethysmography. GYY4137 released H 2 S slowly both in aqueous solution in vitro and after intravenous or intraperitoneal administration in anesthetized rats in vivo. GYY4137 caused a slow relaxation of rat aortic rings and dilated the perfused rat renal vasculature by opening vascular smooth muscle K ATP channels. GYY4137 did not affect rat heart rate or force of contraction in vitro. GYY4137 exhibited antihypertensive activity as evidenced by ability to reduce N G -nitro- l -arginine methyl ester–evoked hypertension in the anesthetized rat and after chronic (14-day) administration in spontaneously hypertensive rats. Conclusions— These results identify GYY4137 as a slow-releasing H 2 S compound with vasodilator and antihypertensive activity. GYY4137 is likely to prove useful in the study of the many and varied biological effects of H 2 S. GYY4137 may also prove of therapeutic value in cardiovascular disease.This publication has 23 references indexed in Scilit:
- Hydrogen sulfide mediates the vasoactivity of garlicProceedings of the National Academy of Sciences of the United States of America, 2007
- Hydrogen sulphide and its therapeutic potentialNature Reviews Drug Discovery, 2007
- Hydrogen sulfide downregulates the aortic l-arginine/nitric oxide pathway in ratsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2007
- Hydrogen sulfide mediates vasoactivity in an O2-dependent mannerAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Hydrogen sulfide‐induces DNA damage and changes in apoptotic gene expression in human lung fibroblast cellsThe FASEB Journal, 2006
- What is the significance of vascular hydrogen sulphide (H2 S)?British Journal of Pharmacology, 2006
- Hydrogen sulfide is a novel mediator of lipopolysaccharide‐induced inflammation in the mouseThe FASEB Journal, 2005
- Hydrogen sulfide‐induced apoptosis of human aorta smooth muscle cells via the activation of mitogen‐activated protein kinases and caspase‐3The FASEB Journal, 2004
- The vasorelaxant effect of H2S as a novel endogenous gaseous KATP channel openerThe EMBO Journal, 2001
- Inhibition of vascular KATP channels by U‐37883A: a comparison with cardiac and skeletal muscleBritish Journal of Pharmacology, 1999